By Will Feuer

CVS Health issued an upbeat revenue forecast for next year and laid out its plans to reinvigorate its pharmacies, including a new pricing strategy.

The company is targeting 2024 revenue of at least $366 billion, above the $344.5 billion that analysts surveyed by FactSet expected and the $351.5 billion to $357.3 billion the company is targeting for this year.

CVS forecast adjusted earnings for next year of at least $8.50 a share. The company in November said 2024 adjusted earnings would likely come in at the lower end of its previous outlook of $8.50 a share to $8.70 a share.

The company said it will provide more detail on its outlook during its investor day.

Write to Will Feuer at Will.Feuer@wsj.com

(END) Dow Jones Newswires

December 05, 2023 07:09 ET (12:09 GMT)

Copyright (c) 2023 Dow Jones & Company, Inc.
CVS Health (NYSE:CVS)
Graphique Historique de l'Action
De Avr 2024 à Mai 2024 Plus de graphiques de la Bourse CVS Health
CVS Health (NYSE:CVS)
Graphique Historique de l'Action
De Mai 2023 à Mai 2024 Plus de graphiques de la Bourse CVS Health